The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 105,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 9,135,392 | 403,685 | SH | SOLE | 403,685 | 0 | 0 | |||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 23,659,178 | 1,241,300 | SH | SOLE | 1,241,300 | 0 | 0 | |||
| AN2 THERAPEUTICS INC | COM | 037326105 | 13,617,142 | 664,575 | SH | SOLE | 664,575 | 0 | 0 | |||
| ANAPTYSBIO INC | COM | 032724106 | 2,570,400 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
| ANNEXON INC | COM | 03589W102 | 9,307,000 | 2,050,000 | SH | SOLE | 2,050,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 168,025,823 | 2,806,980 | SH | SOLE | 2,806,980 | 0 | 0 | |||
| ARCUS BIOSCIENCES INC | COM | 03969F109 | 35,678,800 | 1,868,000 | SH | SOLE | 1,868,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 28,533,516 | 706,800 | SH | SOLE | 706,800 | 0 | 0 | |||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 28,060,481 | 707,526 | SH | SOLE | 707,526 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 16,398,396 | 2,060,100 | SH | SOLE | 2,060,100 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 63,153,975 | 2,673,750 | SH | SOLE | 2,673,750 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 9,684,840 | 116,000 | SH | SOLE | 116,000 | 0 | 0 | |||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 5,761,600 | 554,000 | SH | SOLE | 554,000 | 0 | 0 | |||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 10,546,169 | 792,945 | SH | SOLE | 792,945 | 0 | 0 | |||
| GLYCOMIMETICS INC | COM | 38000Q102 | 7,080,000 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 8,383,943 | 9,187,883 | SH | SOLE | 9,187,883 | 0 | 0 | |||
| GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 5,989,974 | 596,611 | SH | SOLE | 596,611 | 0 | 0 | |||
| IMMUNOVANT INC | COM | 45258J102 | 11,513,666 | 273,289 | SH | SOLE | 273,289 | 0 | 0 | |||
| INOZYME PHARMA INC | COM | 45790W108 | 1,704,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 39,791,160 | 1,284,000 | SH | SOLE | 1,284,000 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM | 471871103 | 3,525,342 | 4,468,114 | SH | SOLE | 4,468,114 | 0 | 0 | |||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 738,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
| NUVATION BIO INC | COM CL A | 67080N101 | 1,510,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 456,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 7,256,200 | 292,000 | SH | SOLE | 292,000 | 0 | 0 | |||
| RENEO PHARMACEUTICALS INC | COM | 75974E103 | 3,600,000 | 2,250,000 | SH | SOLE | 2,250,000 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 28,007,620 | 2,494,000 | SH | SOLE | 2,494,000 | 0 | 0 | |||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 16,874,640 | 414,000 | SH | SOLE | 414,000 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 47,095,720 | 2,369,000 | SH | SOLE | 2,369,000 | 0 | 0 | |||
| VERU INC | COM | 92536C103 | 2,736,000 | 3,800,000 | SH | SOLE | 3,800,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 13,503,600 | 620,000 | SH | SOLE | 620,000 | 0 | 0 | |||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 981,750 | 1,785,000 | SH | SOLE | 1,785,000 | 0 | 0 | |||